Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research

By |2020-08-25T10:10:05+00:00August 1st, 2017|news|Comments Off on Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research

Cambridge Enterprise and specialist growth factor manufacturer Qkine Ltd sign key licensing deal for Activin A production technology